InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2023-06-30 | David P. Joyce(R-OH14) | house | Sale | $15,001 - $50,000 |
No financial data available for XBI.
Company may not file with SEC or CIK is unresolved.
Medical Technology Stocks: Innovation Endures As Valuations Reset
Locking In A Quick Gain In This Biotech ETF Made Room For Better Swing Trades; Here's Why
Gilead Sciences Crosses Critical Breakout Level. The Stock Can Gain 35% From Here.
SBIO: Leaning Into Drug Discovery And Medical Breakthroughs
LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here’s How to Position Now
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)?
Eli Lilly nears $2B-plus deal for Kelonia to expand cancer pipeline: WSJ
JPMorgan analyst sees opportunities in healthcare and financials
AI And The Future Of Healthcare
Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War